These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25857341)

  • 41. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Advanced dementia in Alzheimer's disease and memantine].
    Alberca R
    Rev Neurol; 2005 Feb 1-15; 40(3):173-9. PubMed ID: 15750904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intranasal therapeutic strategies for management of Alzheimer's disease.
    Sood S; Jain K; Gowthamarajan K
    J Drug Target; 2014 May; 22(4):279-94. PubMed ID: 24404923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of huperzine a in the treatment of Alzheimer's disease.
    Desilets AR; Gickas JJ; Dunican KC
    Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug discovery in dementia: the role of rodent models.
    Van Dam D; De Deyn PP
    Nat Rev Drug Discov; 2006 Nov; 5(11):956-70. PubMed ID: 17080031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia.
    Allegri RF; Guekht A
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():25-41. PubMed ID: 22514793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.
    Lee H; Kim E
    Arch Pharm Res; 2020 Sep; 43(9):932-960. PubMed ID: 32909178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
    Grossberg GT
    Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Herbal medicines for the prevention and treatment of Alzheimer's disease.
    Kim HG; Oh MS
    Curr Pharm Des; 2012; 18(1):57-75. PubMed ID: 22316321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dantrolene, a treatment for Alzheimer disease?
    Liang L; Wei H
    Alzheimer Dis Assoc Disord; 2015; 29(1):1-5. PubMed ID: 25551862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies.
    Zhang XW; Chen JY; Ouyang D; Lu JH
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease.
    Athar T; Al Balushi K; Khan SA
    Mol Biol Rep; 2021 Jul; 48(7):5629-5645. PubMed ID: 34181171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Kamkwalala AR; Newhouse PA
    Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug therapy for Alzheimer's disease].
    Shoji M
    Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current and novel therapeutic molecules and targets in Alzheimer's disease.
    Kumar A; Nisha CM; Silakari C; Sharma I; Anusha K; Gupta N; Nair P; Tripathi T; Kumar A
    J Formos Med Assoc; 2016 Jan; 115(1):3-10. PubMed ID: 26220908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The development of new therapeutics for Alzheimer's disease.
    Carter MD; Simms GA; Weaver DF
    Clin Pharmacol Ther; 2010 Oct; 88(4):475-86. PubMed ID: 20811351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments in Alzheimer's disease therapeutics.
    Rafii MS; Aisen PS
    BMC Med; 2009 Feb; 7():7. PubMed ID: 19228370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics.
    Cheng X; Zhang L; Lian YJ
    Biomed Res Int; 2015; 2015():760758. PubMed ID: 26665008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.